Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Lance Okeke

HIV/AIDS Medicine · Duke University

View

Dr. Aniruddha Hazra

HIV/AIDS Medicine · UCMC

View

Dr. Shital Patel

HIV/AIDS Medicine · BCM

View

Dr. Monica Gandhi

HIV/AIDS Medicine · UCSF

View

Dr. Ashwin Balagopal

HIV/AIDS Medicine · Johns Hopkins

View

Dr. Ofole Mgbako

HIV/AIDS Medicine · NYU Langone

View

Dr. Joshua Barocas

HIV/AIDS Medicine · CU Anschutz Medical Campus

View

Dr. Chris Beyrer

Global Health · Duke University

View

Dr. Keith Kaye

General ID · RU

View

Dr. Helen Boucher

Transplant/Immunocompromised States · Tufts

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges

    Feb 26, 2026DOI: 10.1056/nejmoa2508228Original ArticleNEJM

    Written by: Aadia I. Rana, M.D.Lu Zheng, Ph.D.Jose Castillo-Mancilla, M.D.Yajing Bao, M.S.Sara Sieczkarski, Ph.D.Kristina M. Brooks, Pharm.D.Jordan E. Lake, M.D.Carl Fichtenbaum, M.D.Sonya L. Heath, M.D.Pablo F. Belaunzaran-Zamudio, M.D.Karin Klingman, M.D.Lawrence Fox, M.D.Tia Morton, R.N., M.S.Michael Stirratt, Ph.D.Jonathan Z. Li, M.D., M.M.Sc.Edward P. Acosta, Pharm.D.Charles Venuto, Pharm.D.Omar Galárraga, Ph.D.Steven Shoptaw, Ph.D.David Wohl, Ph.D.Madison Green, B.S.Ceora Beijer, B.S.Kathie Ferbas, Ph.D.Cheryl Jennings, B.S.Katherine Shin, Pharm.D.Romina Collahua, M.Sc.Michael Dorosh, M.A.Paul Wannamaker, B.A.Ronald D’Amico, M.D.Kimberly Smith, M.D., M.P.H.William Spreen, Pharm.D.Kati Vandermeulen, M.Sc.Rodica Van Solingen-Ristea, M.D.Chanelle Wimbish, B.S.Karen T. Tashima, M.D.Raphael J. Landovitz, M.D.

    Find these authors on Roon

    RL
    Dr. Raphael J. Landovitz
    HIV/AIDS Medicine · UCLA
    [Free Article]

    Summary

    In persons with HIV and barriers to adhering to antiretroviral therapy, a long-acting injectable treatment (monthly cabotegravir plus rilpivirine) resulted in better virologic control than standard oral ART.
    RLDr. Raphael J. Landovitz
    Leading Voice

    Dr. Raphael J. Landovitz

    Infectious Disease · HIV & AIDS Medicine
    University of California, Los Angeles
    raphaell
    Los Angeles, CA, USA